Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Understanding which assets have the highest returns can guide your investment strategy. Explore various options to enhance your portfolio.
25,689 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
The waiver for Russian crude expires, ending limited relief as oil markets tighten and fuel costs threaten households...
A major fund boosted its Nomad Foods stake as the stock faced a tough year. Explore what this move means for risk, va...
ETH fell below the $2,000 level, renewing talk of further declines. Market metrics and crowd sentiment suggest the do...
Mega IPOs spark big bets and bigger headlines. This guide unpacks whether elon musk selling 'hopium' is fueling Space...
A sensational gain like sandisk more than 4,900% grabs headlines, but smart investors focus on fundamentals, risk, an...
Bitmine filed for a public offering of 3 million shares of a 9.50% perpetual preferred stock to accelerate ETH holdin...
As 2026 unfolds, three robotics stocks stand out in the M&A spotlight, driven by cash flow, autonomous tech stacks, a...
A loomingFed policy shift could push up borrowing costs for households. Analysts warn americans taxpayers could face ...
MercadoLibre reports 40% year-over-year growth fueled by fintech expansion and a resilient e-commerce network in Lati...
When defense budgets shift or quarterly results miss expectations, even blue-chip stocks can move. This guide explain...
A high-net-worth retiree in washington discovers that a single Social Security claiming choice could cut his lifetime...